(Q34570571)

3 August 2017

1 reference

title

Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

1 reference

1

0 references

Lawrence James Hirsch

series ordinal

2

object named as

Lawrence J Hirsch

0 references

Stephan A. Mayer

object named as

4

0 references

author name string

Ronald G Emerson

series ordinal

3

1 reference

3 August 2017

publication date

1 February 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

43

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

146-153

1 reference

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Refractory status epilepticus: frequency, risk factors, and impact on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Use of midazolam in the treatment of refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Role of propofol in refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Double-blind Study of Lorazepam and Diazepam in Status Epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Midazolam in refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Pharmacokinetic implications for the clinical use of propofol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Pentobarbital treatment of refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Propofol infusion for the treatment of status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Treatment of refractory generalized status epilepticus with continuous infusion of midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Prolongation of midazolam half-life after sustained infusion for status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Propofol and midazolam in the treatment of refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Propofol infusions for status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Propofol infusion for control of status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Successful use of propofol in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Propofol for refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Successful treatment of amoxapine-induced refractory status epilepticus with propofol (diprivan)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Treatment of refractory complex-partial status epilepticus with propofol: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Large trials vs meta-analysis of smaller trials: how do their results compare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Discrepancies between meta-analyses and subsequent large randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Short-term mortality after a first episode of status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Status epilepticus at an urban public hospital in the 1980s

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Determinants of mortality in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Propofol. An update of its use in anaesthesia and conscious sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

Predictive ability of meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.28501.X

10.1046/J.1528-1157.2002.28501.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference